非参数贝叶斯局部-全局模型提升自发报告系统不良事件信号检测
针对自发报告系统中罕见不良事件或新药信号检测统计功效不足的问题,提出基于局部-全局混合Dirichlet过程先验的非参数贝叶斯模型,捕捉药物间信号强度关联以实现信息共享,并采用FDR控制、FNR优化的假设检验框架。模拟显示方法灵敏度常提升两倍以上且严格控FDR,应用于FDA FAERS他汀类药物数据验证有效性。
要点
- 局部-全局混合DP先验可借用药物间信号强度关联提升罕见AE检测功效。
- 配套MCMC算法与FDR控制、FNR优化的检验框架实现信号检测。
- 模拟中灵敏度常超现有方法两倍以上,且严格控制系统FDR。
核心结论
- 所提非参数贝叶斯局部-全局模型通过药物间信息共享提升自发报告系统AE信号检测的统计功效。
研究设计与样本
- 方法学研究:提出局部-全局混合Dirichlet过程先验的非参数贝叶斯模型,并开发MCMC算法与FDR控制、FNR优化的假设检验框架。
主要发现
- 广泛模拟显示所提方法灵敏度常超过现有方法两倍或以上,同时严格控制系统FDR。
- 应用于FDA FAERS他汀类药物数据进一步显示方法在真实世界AE信号检测中的有效性。
临床怎么用
- 可用于上市后药品不良反应信号检测,尤其针对罕见AE或新药等计数偏小、统计功效不足的场景。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Spontaneous reporting system databases are key resources for post-marketing surveillance, providing real-world evidence (RWE) on the adverse events (AEs) of regulated drugs or other medical products. Various statistical methods have been proposed for AE signal detection in these databases, flagging drug-specific AEs with disproportionately high observed counts compared to expected counts under independence. However, signal detection remains challenging for rare AEs or newer drugs, which receive small observed and expected counts and thus suffer from reduced statistical power. Principled information sharing on signal strengths across drugs/AEs is crucial in such cases to enhance signal detection. However, existing methods typically ignore complex between-drug associations on AE signal strengths, limiting their ability to detect signals. We propose novel local-global mixture Dirichlet process (DP) prior-based nonparametric Bayesian models to capture these associations, enabling principled information sharing between drugs while balancing flexibility and shrinkage for each drug, thereby enhancing statistical power. We develop efficient Markov chain Monte Carlo algorithms for implementation and employ a false discovery rate (FDR)-controlled, false negative rate (FNR)-optimized hypothesis testing framework for AE signal detection. Extensive simulations demonstrate our methods' superior sensitivity-often surpassing existing approaches by a twofold or greater margin-while strictly controlling the FDR. An application to FDA FAERS data on statin drugs further highlights our methods' effectiveness in real-world AE signal detection. Software implementing our methods is provided as supplementary material.
引用
- Huang XW, Chakraborty S. A Nonparametric Bayesian Local-Global Model for Enhanced Adverse Event Signal Detection in Spontaneous Reporting System Data. Stat Med. 2026. PMID: 41944338. doi:10.1002/sim.70523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。